Does NIRSEVIMAB Cause Enteral nutrition? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Enteral nutrition have been filed in association with NIRSEVIMAB (BEYFORTUS). This represents 3.6% of all adverse event reports for NIRSEVIMAB.
9
Reports of Enteral nutrition with NIRSEVIMAB
3.6%
of all NIRSEVIMAB reports
0
Deaths
9
Hospitalizations
How Dangerous Is Enteral nutrition From NIRSEVIMAB?
Of the 9 reports, 9 (100.0%) required hospitalization.
Is Enteral nutrition Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIRSEVIMAB. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does NIRSEVIMAB Cause?
Respiratory syncytial virus bronchiolitis (87)
Drug ineffective (65)
Respiratory syncytial virus infection (38)
Cough (19)
Pyrexia (15)
Apnoea (14)
Bronchiolitis (14)
Wheezing (13)
Incorrect dose administered (12)
Syringe issue (11)
What Other Drugs Cause Enteral nutrition?
CARBIDOPA\LEVODOPA (239)
USTEKINUMAB (24)
VEDOLIZUMAB (23)
METHOTREXATE (21)
PREDNISOLONE (20)
ADALIMUMAB\ISOPROPYL ALCOHOL (18)
ADALIMUMAB (16)
CYCLOPHOSPHAMIDE (9)
PANCRELIPASE AMYLASE\PANCRELIPASE LIPASE\PANCRELIPASE PROTEASE (6)
CINACALCET (5)
Which NIRSEVIMAB Alternatives Have Lower Enteral nutrition Risk?
NIRSEVIMAB vs NIRSEVIMAB-ALIP
NIRSEVIMAB vs NITAZOXANIDE
NIRSEVIMAB vs NITISINONE
NIRSEVIMAB vs NITRAZEPAM
NIRSEVIMAB vs NITRENDIPINE